An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...

A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...

Glucagon-like peptide-1 receptor agonist (GLP-1) drugs, such as semaglutide, have become well known for their ability to aid in weight loss.

Compounded semaglutide, meanwhile, contains the same active ingredient as Ozempic, semaglutide. However, this medication is not approved by the FDA, and it may pose risks to those who take it, ...

A phase 3 trial found the daily pill orforglipron lowered HbA1c more than oral semaglutide in adults with type 2 diabetes. It ...

The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging ...

OpenAI CEO Sam Altman said that he tried semaglutide "before it was cool," and his busy life has made it harder to focus on his health.

Researchers published findings on June 3, 2026, describing an oral pill that burns fat by targeting skeletal muscle and brown ...

Compounded forms of semaglutide and tirzepatide were being sold by dozens of compounded pharmacies from August to October ...

PvPI urges public for timely reporting of ADRs to strengthen safety monitoring of diabetes drug semaglutide: Shardul Nautiyal, Mumbai Monday, July 20, 2026, 08:00 Hrs [IST] Recogn ...

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the ...

Dr. Reddy's Laboratories (NYSE:RDY) said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide ...